Top 10 Companies in the Global Bioresorbable Surgical Material Market (2025): Innovators Redefining Post-Surgical Recovery

In Business Insights
August 07, 2025

The Global Bioresorbable Surgical Material Market was valued at USD 2.1 Billion in 2023 and is projected to reach USD 3.8 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period (2024–2030). This expansion stems from rising demand for minimally invasive procedures, material science breakthroughs, and the increasing prevalence of chronic conditions requiring surgical intervention.

As healthcare transitions toward biodegradable solutions that eliminate secondary removal surgeries, leading manufacturers are pioneering next-generation biomaterials with optimized absorption rates and biocompatibility. This analysis profiles the Top 10 Companies in the Bioresorbable Surgical Material Market—trailblazers in medical polymers and implant technologies transforming surgical outcomes worldwide.


🔟 1. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: RESOMER® biodegradable polymers (PLA, PGA, PCL)

Evonik dominates with its RESOMER® polymer platform, providing customizable degradation profiles for sutures, fixation devices, and drug-eluting implants. These FDA-approved materials are widely adopted in cardiovascular and orthopedic applications for their predictable resorption kinetics.

Innovation Benchmarks:

  • RESOMER® Select system enabling precise degradation rate customization
  • Strategic partnerships with 18+ medical device manufacturers
  • €25 million investment in new GMP-certified polymer facilities (2023)

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/272175/global-bioresorbable-surgical-material-market-2024-932


9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: PURASORB® medical-grade polyesters

Corbion supplies 30% of global medical-grade lactide monomers, specializing in high-purity lactic acid-based materials. Their PURASORB® polymers demonstrate superior load-bearing capacity for bone fixation applications.

Innovation Benchmarks:

  • Patented stereo-complex PLA technology for enhanced strength
  • FDA Master Files covering 12 polymer formulations

8️⃣ 3. DSM Biomedical

Headquarters: Heerlen, Netherlands
Key Offering: Dyneema Purity® UHMWPE fibers

DSM Biomedical leads the absorbable fiber segment with ultra-high-molecular-weight polyethylene products featuring exceptional tensile strength and controlled absorption profiles.

Innovation Benchmarks:

  • First commercially available bioresorbable hernia mesh (2022)
  • Collaborative R&D programs with Mayo Clinic

7️⃣ 4. Mitsui Chemicals, Inc.

Headquarters: Tokyo, Japan
Key Offering: LACTEL® absorbable polymers

Mitsui Chemicals maintains Japan’s most comprehensive portfolio of medical-grade resorbable polyesters, particularly strong in drug-eluting stent applications across Asia-Pacific markets.

Innovation Benchmarks:

  • Advanced bi-layer stent coating technology
  • Closed-loop recycling system for production waste

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/272175/global-bioresorbable-surgical-material-market-2024-932


6️⃣ 5. PCAS (PolymerExpert)

Headquarters: Bazet, France
Key Offering: EXPANSORB® smart polymers

PCAS specializes in stimuli-responsive bioresorbable materials with programmable degradation profiles, particularly for neurological and ophthalmic applications requiring precise absorption timing.

Innovation Benchmarks:

  • pH-sensitive polymer technology platform
  • CE Mark approval for EXPANSORB®-M neurosurgical mesh

5️⃣ 6. Poly-Med, Inc.

Headquarters: Anderson, South Carolina, USA
Key Offering: Bioresorbable composites

This U.S. innovator develops fiber-reinforced composites combining PLA/PGA polymers with hydroxyapatite, mimicking bone’s mechanical properties for orthopedic trauma applications.

Innovation Benchmarks:

  • 17 active patents in composite formulations
  • Multiple DoD contracts for combat-ready implants

4️⃣ 7. KLS Martin Group

Headquarters: Tuttlingen, Germany
Key Offering: RESORP X® craniofacial solutions

KLS Martin pioneers biodegradable fixation systems for facial reconstruction, with materials engineered to match bone healing phases (12-24 months absorption).

Innovation Benchmarks:

  • 3D-printed resorbable mesh technology
  • Over 500,000 RESORP X® implants placed worldwide

3️⃣ 8. Zimmer Biomet

Headquarters: Warsaw, Indiana, USA
Key Offering: OSSIS bone substitutes

Zimmer Biomet’s biomaterials division focuses on calcium phosphate and collagen-based resorbables for dental and orthopedic void filling applications.

Innovation Benchmarks:

  • Nano-crystalline hydroxyapatite platform
  • FDA 510(k) clearance for curved resorbable mesh (2023)

2️⃣ 9. Medtronic plc

Headquarters: Dublin, Ireland
Key Offering: VICRYL® absorbable sutures

Through its Ethicon subsidiary, Medtronic offers the world’s most widely used bioresorbable sutures, featuring glycolide/lactide copolymers with 60-90 day absorption profiles.

Innovation Benchmarks:

  • Antimicrobial VICRYL Plus® with triclosan coating
  • AI-powered absorption prediction algorithms

1️⃣ 10. Smith & Nephew

Headquarters: London, UK
Key Offering: REGENETEN® collagen scaffolds

Smith & Nephew leads in natural-origin resorbables, with bovine collagen implants for soft tissue regeneration that fully assimilate within 18 months.

Innovation Benchmarks:

  • 95% porosity for optimal cell infiltration
  • Clinical use in 500,000+ rotator cuff repairs

Get Full Report Here: https://www.24chemicalresearch.com/reports/272175/global-bioresorbable-surgical-material-market-2024-932


🔬 Outlook: The Next Frontier in Absorbable Medical Technologies

The bioresorbable materials sector is entering a transformative phase, with emerging innovations converging material science, digital health, and personalized medicine.

📈 Market-Defining Trends:

  • 3D printing of patient-specific implants (Projected CAGR: 23%)
  • Oncology applications with drug-eluting resorbables (85 active clinical trials in 2024)
  • Shift toward bioengineered collagen/hyaluronic acid systems
  • Global standardization of absorption testing protocols

Get Full Report Here: https://www.24chemicalresearch.com/reports/272175/global-bioresorbable-surgical-material-market-2024-932

These industry leaders aren’t just developing materials—they’re creating a future where surgical interventions facilitate healing without permanent implants.